Back to Blog

Blog

Employers Are Being Advised to Ask Mental Health Care for Outcomes

Q1 2026 results from four public companies, an employer push for quality reporting, and what makes an outcome claim defensible.

July 5, 2026
7 min read
By Declan Ahern
outcomes trackingvalue-based carepractice growthclinical evidencepayer contractsPHQ-9GAD-7

Employers that buy mental health care are being advised to ask for evidence that it works. In its survey of employers for 2026, Business Group on Health told them to focus on cost and on "high-quality, appropriate treatment," and told mental health vendors to report on quality outcomes.1 This post covers what four public companies reported for the first quarter of 2026, why an outcome claim is hard to defend, and what a practice can do about it.

Growth has come from volume

In the first quarter of 2026, Talkspace's revenue from health plans and employee assistance programs grew 28%, to $48.6 million. The number of sessions its clinicians completed for members covered by those payers grew faster, by 31%, to about 459,300.2 Divide one figure by the other and revenue per payer session comes to about $106, against about $108 a year earlier, a fall of about 2%.

Talkspace does not report this figure; it is calculated here from the filing, and it is not a price. Payer revenue may include items other than sessions, and revenue per session moves when the mix of payers or services changes. Over the same year Talkspace's health plan customers rose from 31 to 38 and its enterprise customers fell from 173 to 153. The filing describes the company's overall revenue growth as "predominantly volume-driven," reflecting a shift in its revenue mix toward payers.

For two decades, US mental health spending grew mainly because more people got treatment. A 2026 Health Affairs analysis of Bureau of Economic Analysis data found that 87.3% of the growth in mental health and substance use spending between 2000 and 2021 came from more people being treated, and 12.7% from higher spending per case.3 Talkspace's quarter fits that history. Three other public companies with large mental health businesses reported different results for the same quarter, and one quarter of earnings cannot show whether the history is changing.

What four public companies reported for Q1 2026

The four results do not share one pattern.456

CompanyQ1 2026 against Q1 2025What the company said drove it
LifeStanceRevenue up 21%, to $403.5 millionMore clinicians (up 11%, to 8,349), more visits (up 18%, to 2.5 million), higher revenue per visit
TalkspacePayer revenue up 28.3%Payer sessions up 31.2%; revenue per payer session down about 2% (calculated, see above)
AcadiaSame-facility revenue up 7.3%: revenue per patient day up 5.6%, patient days up 1.6%Mostly revenue per patient day, partly from state supplemental payments from Tennessee and Ohio that were not in the prior-year period
BetterHelp (Teladoc)Segment revenue down 9%, to $218.4 millionTeladoc says it is scaling insurance acceptance at BetterHelp

LifeStance and Talkspace grew mainly by adding visits and sessions; LifeStance's revenue grew a little faster than its visits, so its revenue per visit also rose. Acadia grew mainly on rate, and it runs inpatient and residential facilities, a different business from outpatient therapy. BetterHelp shrank, and its parent says it is scaling insurance acceptance there.

A business that grows mainly by adding sessions grows as fast as it can hire clinicians and fill their calendars. LifeStance shows that this can work. Growth of that kind gives one company little to say to an insurer or an employer that a competitor cannot also say, a problem the post on why therapy marketplaces still depend on insurers follows for platforms such as Talkspace.

Employers are being advised to ask about quality

In Business Group on Health's survey for 2026, 73% of employers reported more use of mental health and substance use services, which the group attributed partly to employers' own work on access and stigma. Its advice was that, with access improved and use high, employers should now focus on unit cost and on "high-quality, appropriate treatment," and that mental health vendors should give employers reporting on quality outcomes.1

Two of the companies above have started to talk about outcomes. In LifeStance's Q1 2026 results release, its chief executive pointed to an outcomes study of about 180,000 of its clients, in which roughly three quarters reported clinically significant improvement in anxiety and depression.4 At the J.P. Morgan Healthcare Conference in January 2026, Talkspace's chief executive told investors that the company has "defined, measured outcomes" and has developed value-based contracts with payers.7

Why "three quarters improved" is where the questions start

An outcome claim is easy to make and hard to defend. Before-and-after figures from a company's own clients have no comparison group, so they cannot show how much of the change would have happened anyway. Clients who stay in care long enough to be measured again may also differ from those who leave early. LifeStance's figure may be accurate, and a skeptical buyer will still ask how much of the improvement the care caused, which that figure alone cannot answer.

In May 2026, The Hemingway Report published a guide by Steve Duke, written with Jen Huberty, a former head of science at Calm, that gives a useful test for this.8 It argues that a defensible claim rests on four foundations that depend on each other: the problem, the population, the solution and the outcomes. Weakness in one undermines the others, and strong outcome data alone still leaves a buyer asking whom the solution works for and whether it is what produced the results. The guide also advises deciding which claims matter for a company's near-term goals and making those defensible first.

Compare two statements a group practice might make, both invented for illustration. The first: "Our clients' PHQ-9 scores improve on average." The second: "Clients who started with moderate or severe depression scores showed a clinically meaningful drop by their sixth session, and most still had it three months later." The second tells a referrer or a health plan whom the evidence describes, when it was measured, and whether the change lasted. It still does not show that the care caused the change, but it gives a buyer something specific to test.

What a practice can do without a public company's scale

Business Group on Health asks mental health vendors to report on quality outcomes, and the Hemingway guide adds that a buyer will ask whom a claim covers. A practice can answer both only if its clinicians have used the same validated questionnaires over time, so that change from each client's own starting point can be reported for a defined group, such as clients who began with moderate or severe symptoms. When to measure, and which measures fit which clients, is the clinician's call; this guide to assessments beyond PHQ-9 and GAD-7 covers the main options. The Hemingway guide's advice on priorities fits a practice too: decide which one or two claims matter for a near-term goal, such as a specific payer contract or referral relationship, and make those defensible first.

Citt handles the reminders and the arithmetic. It sends a baseline set of assessments (including PHQ-9 and GAD-7) when a client starts, tells the therapist when a follow-up is due at 4, 8 and 12 weeks and at 6 months, and leaves the therapist to decide whether to send it. The therapist then sees each client's change from baseline. We have no evidence yet that Citt improves outcomes; our evidence roadmap covers what we measure and what we have not shown. A practice's change-from-baseline figures share the limit of LifeStance's: without a comparison group, they leave open how much of the change the care caused.

Footnotes

  1. Business Group on Health. (August 19, 2025). 2026 Employer Health Care Strategy Survey: executive summary. An employer survey; it reports employers' experience and the group's recommendations, not measured outcomes. ↩ ↩2

  2. Talkspace, Inc. (2026). Form 10-Q for the quarterly period ended March 31, 2026. US Securities and Exchange Commission. "Payor" revenue (health insurance plans and employee assistance programs) was $48.6 million, up 28.3%; completed sessions for payer-covered members were about 459,300, against 350,000 a year earlier (up 31.2%). At period end the company had 38 health plan customers against 31, and 153 enterprise customers against 173. The filing calls overall revenue growth "predominantly volume-driven reflecting a shift in revenue mix towards Payor." Talkspace does not report revenue per session; the figure in the text is calculated from the revenue and session numbers. ↩

  3. Mark, T. L., Fernando, L., Shieh, P., & Dunn, A. (2026). US national spending on mental health and substance use disorder treatment driven by case growth, 2000-21. Health Affairs, 45(4), 365-371. Based on the Bureau of Economic Analysis Health Care Satellite Account. The authors note that severity was not observed, so part of the growth may be more people with milder conditions entering treatment. ↩

  4. LifeStance Health Group. (May 7, 2026). LifeStance reports first quarter 2026 results. The outcomes figure is the company's own statement; the release does not describe the study's method or any comparison group. ↩ ↩2

  5. Acadia Healthcare. (April 29, 2026). Acadia Healthcare announces first quarter 2026 results. Same-facility revenue rose 7.3%, driven by a 1.6% increase in patient days and a 5.6% increase in revenue per patient day. The release does not quantify how much of the 5.6% came from supplemental payments. ↩

  6. Teladoc Health. (April 29, 2026). Teladoc Health reports first quarter 2026 results. ↩

  7. Talkspace presentation at the 44th Annual J.P. Morgan Healthcare Conference, January 15, 2026. Transcript. Remarks by chief executive Jon Cohen. ↩

  8. Duke, S., with Huberty, J. (May 14, 2026). How to build scientific credibility as a digital mental health business. The Hemingway Report. ↩

Frequently Asked Questions

What are employers being advised to ask of mental health vendors?

Business Group on Health's 2026 survey advised employers, now that access to mental health care and its use have grown, to focus on cost and on high-quality, appropriate treatment. It also advised mental health vendors to give employers reporting on quality outcomes.

What did Q1 2026 earnings show at public mental health companies?

The results did not move together. LifeStance and Talkspace grew mainly by adding visits and sessions, Acadia grew mainly through higher revenue per patient day, and BetterHelp's revenue fell 9% as Teladoc worked to accept more insurance there.

What makes outcome evidence convincing to a payer or referrer?

It says which clients it covers, uses validated measures such as PHQ-9 or GAD-7, and shows whether the change lasted. The hardest part is showing that the care caused the change, which before-and-after figures without a comparison group cannot do.

Does a small practice need to think about this?

It does if it wants to negotiate with payers or win referrals on more than availability. A practice can report change only if its clinicians have used the same validated measures over time; when to measure and which measures to use stay the clinician's call.

Stop rewriting notes from scratch

Citt.ai drafts session notes under your review, keeps between-session context in one place, and stays therapist-led. Start free. No card required.